Latest News & Features
Americas
Anglo-Swedish pharmaceutical company AstraZeneca has sued India-based Zydus for infringing three patents related to its heartburn drug Nexium (esomeprazole magnesium). 4 August 2014
Americas
Pfizer has entered into a definitive agreement to acquire two vaccines marketed by US biotechnology company Baxter International for $635 million. 31 July 2014
Americas
German pharmaceutical company Boehringer Ingelheim has sued generic drug maker Mylan for infringing a patent covering its Aggrenox drug. 31 July 2014
Americas
The expiration of US pharmaceutical company Pfizer’s patent for Viagra in many European countries was a contributing factor to the drop in revenue that it reported yesterday (July 29) when releasing its second-quarter earnings data. 30 July 2014
Big Pharma
UK-based pharmaceutical company AstraZeneca has boosted its patent portfolio with the acquisition of rights to Spanish company Almirall’s lung drugs, including Eklira (aclidinium). 30 July 2014
Americas
DLA Piper has appointed life sciences lawyer Shane Albright to its corporate and finance practice. 29 July 2014
Americas
US officials have accepted an application by Novartis to market a biosimilar of Amgen’s Neupogen (filgrastim) drug, a move thought to be the first of its kind. 29 July 2014
Europe
Justice Arnold of the England and Wales High Court has decided to reverse a previous decision and grant Pfizer subsidiary Pharmacia its application to stay Actavis’s patent revocation action against it. 28 July 2014
Americas
Law firm Dechert LLP has bolstered its life sciences team with the hire of Scott Warren as a partner in its IP practice in New York. 25 July 2014
Biotechnology
German medical device company Occlutech has successfully defeated US-based AGA Medical Corporation after the English High Court declared a patent AGA was trying to assert invalid. 25 July 2014